- Home
- CDLR vs BCRX Comparison
CDLR vs BCRX Comparison
Compare CDLR & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLR
- BCRX
- Stock Information
- Founded
- CDLR 2008
- BCRX 1986
- Country
- CDLR Denmark
- BCRX United States
- Employees
- CDLR N/A
- BCRX N/A
- Industry
- CDLR
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CDLR
- BCRX Health Care
- Exchange
- CDLR Nasdaq
- BCRX Nasdaq
- Market Cap
- CDLR 1.9B
- BCRX 1.8B
- IPO Year
- CDLR N/A
- BCRX 1994
- Fundamental
- Price
- CDLR $21.23
- BCRX $7.91
- Analyst Decision
- CDLR
- BCRX Strong Buy
- Analyst Count
- CDLR 0
- BCRX 10
- Target Price
- CDLR N/A
- BCRX $16.70
- AVG Volume (30 Days)
- CDLR 47.9K
- BCRX 2.2M
- Earning Date
- CDLR 08-26-2025
- BCRX 11-03-2025
- Dividend Yield
- CDLR N/A
- BCRX N/A
- EPS Growth
- CDLR N/A
- BCRX N/A
- EPS
- CDLR 0.78
- BCRX N/A
- Revenue
- CDLR $546,159,718.00
- BCRX $557,506,000.00
- Revenue This Year
- CDLR $116.02
- BCRX $41.37
- Revenue Next Year
- CDLR $80.90
- BCRX $7.56
- P/E Ratio
- CDLR $6.80
- BCRX N/A
- Revenue Growth
- CDLR 277.89
- BCRX 45.85
- 52 Week Low
- CDLR $17.37
- BCRX $6.02
- 52 Week High
- CDLR $28.75
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- CDLR 51.41
- BCRX 34.55
- Support Level
- CDLR $20.85
- BCRX $7.93
- Resistance Level
- CDLR $21.70
- BCRX $8.13
- Average True Range (ATR)
- CDLR 0.37
- BCRX 0.22
- MACD
- CDLR 0.03
- BCRX -0.03
- Stochastic Oscillator
- CDLR 53.72
- BCRX 2.53
About CDLR Cadeler AS
Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.